SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001493152-21-013990
Filing Date
2021-06-10
Accepted
2021-06-10 13:48:37
Documents
3

Document Format Files

Seq Description Document Type Size
1 formsc-13d.htm SC 13D 62932
2 ex1.htm EX-1 56696
3 ex2.htm EX-2 58882
  Complete submission text file 0001493152-21-013990.txt   179877
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Subject) CIK: 0001569340 (see all company filings)

IRS No.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91841 | Film No.: 211007651
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELL SOURCE, INC. 65 YIGAL ALON STREET TEL AVIV L3 67433
Business Address
SHIMRAT ITAMAR (Filed by) CIK: 0001638324 (see all company filings)

Type: SC 13D